3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
21
Uterine Cervical Neoplasms
15
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Vaginal Neoplasms
2
Rhabdomyosarcoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Melanoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrent Head and Neck Carcinoma
1
Prostatic Diseases
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Gynecologic Cancer
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Clear Cell Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Brachytherapy
×
1 year
×
Clear all
No trials found.